Positive Health Online
Your Country
Research Updates: cancer
Below are short extracts from research updates about this subject - select more to read each item.
-
Issue 116
HANA and co-authors, Quality Improvement Unit, Rambam Medical Center, Haifa, Israel, have surveyed the use of complementary and alternative medicine for cancer in Northern Israel.
-
Issue 116
HYODO and co-workers, Medical Oncology Division, National Shikoku Cancer Center, Horinouchi 13, Matsuyama, 790-0007 Ehime, Japan, ihyodo@shikoku-cc.go.jp, have surveyed the use of complementary and alternative medicine for c1
-
Issue 116
LAFFERTY and colleagues, Department of Health Sciences, University of Washington, Seattle, Washington 98195, USA, billlaf@u.washington.edu, have surveyed the use of complementary and alternative medicine by cancer patients 1
-
Issue 114
JIAN and colleagues, School of Public Health, Curtin University of Technology, Perth, Australia, have investigated whether lycopene and other carotenoids afford protection against prostate cancer.
-
Issue 114
KIM and KIM, St Mary's Hospital, The Catholic University, Seoul 137-701, Korea, have described the effects of a relaxation breathing exercise on fatigue in patients undergoing bone marrow transplantation.
-
Issue 114
VAN WEERT and others, Department of Rehabilitation, University Hospital Groningen, The Netherlands, Evw@IKN.nl, have investigated physical functioning and quality of life after cancer rehabilitation.
-
Issue 113
JAMISON and colleagues, Department of Urology, College of Medicine, Northeastern Ohio Universities, Summa Health System/NEOUCOM, Akron, OH 44304, USA, jmj@neoucom.edu, have treated a human bladder carcinoma cell line with vitamins C1
-
Issue 113
MOYAD, University of Michigan Medical Center-Dept. of Urology, Ann Arbor, MI, USA, has reviewed (33 references) regarding zinc for prostate disease and other conditions. Abstract:/b Dietary and supplemental zinc has received much attention in numerous altern1
-
Issue 113
POMMIER and co-workers, Department of Radiation Oncology, Centre Leon Berard, 28 rue Laennec, 69373 Lyon Cedex 08, France, have tested Calendula for the prevention of dermatitis during irradiation for breast cancer.
-
Issue 113
THELEN and colleagues, Department of Urology, Institute of Human Genetics, Georg-August-University, Gottingen, Germany, have researched the inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
-
Issue 112
CUI and others, Department of Medicine, Center for Health Services Research and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN37232-8300, USA, have investigated the use of complementary and alternative medicine by Chinese women with breast cancer.
-
Issue 112
LI and colleagues, Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China, have studied the prevention of stomach cancer by selenium and garlic.
-
Issue 112
GOODMAN and co-workers, Fred Hutchinson Cancer Research Center, 1100 Fairview Avene North, Building M, M1-B514, Seattle, WA 98109, USA, gary.goodman@swedish.org, have reported on the 6-year follow-up of the beta-carotene an1
-
Issue 112
VICKERS and co-workers, Integrative Medicine Service and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY10021, USA, vickers.a@mskcc.org, have studied acupuncture for post-chemotherapy fatigue.
-
Issue 110
GENKINGER and co-workers, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA, have studied the link between fruit, vegetables, and antioxidant consumption and death from cancer and cardiovascula1
-
Issue 110
ROSENBAUM, SPIEGEL and colleagues, Stanford Cancer Supportive Care Program, Stanford Hospital and Clinics, 1101 Welch Road, Bldg. A, Ste. 6, Stanford, CA 94305, USA, ernie@lmi.net, have evaluated a programme of supportive cancer care 1
-
Issue 110
KOLSTAD and co-workers, Department of Oncology, The Norwegian Radium Hospital, 0310, Oslo, Norway, arnkolst@online.no, have investigated the use of complementary and alternative medicine amongst oncology health professionals in Norway.
-
Issue 109
MARTARELLI and others, Department of Pharmacological Sciences and Experimental Medicine, University of Camerino, ViaMarcello Scalzino 3, Camerino (MC) 62032, Italy, daniele.martarelli@unicam.it, have found that St John'1
-
Issue 109
SINGH and AGARWAL, Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Cancer Center, 4200 East Ninth Avenue, Denver, CO 80262, USA, have reviewed (118 references) the prevention of prostate cancer by silibinin. Abstract: On1
-
Issue 109
WRIGHT and co-workers, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA, wrighmar@mail.nih.gov, have developed a comprehensive dietary antioxidant index and applied it to eva1